SEC Form D · filed October 2, 2015
Antegrin Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Robert W. Karr · St. Louis, MOExec · DirectorRajesh J. Devraj · St. Louis, MODirectorDavid W. Griggs · St. Louis, MODirectorCharles A. Bolten · St. Louis, MODirectorMichael W. Yeadon · St. Louis, MODirectorThomas P. Cirrito · St. Louis, MODirectorGeorge H. Capps, Ii · St. Louis, MOExecPaul Wozniak · San Francisco, CAExecWilliam C. Perkins · Madison, WIExec · DirectorMichael J. Taylor · Solon, OHDirectorScott D. Macdonald · Toronto, Ontario, CanadaDirectorJonathan Rigby · San Ramon, CADirectorBrian J. Maher · Vancouver, British Columbia, CanadaDirectorElizabeth W. Cermak · San Ramon, CADirectorJames C. Stretz · Denver, COExecJorge D. Benavides Alfaro · Vancouver, British Columbia, CanadaExec · DirectorJames L. Logue, Iii · Lansing, MIDirectorBrian D. Imrie · Vancouver, British Columbia, CanadaDirectorDonald W. Huffman · San Ramon, CADirectorDiego D. De La Torre De La Piedra · Vancouver, British Columbia, CanadaDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗